chartexchange

Rani Therapeutics Reports Third Quarter 2026 Financial Results; Provides Corporate Update

GlobeNewswire Inc. | Nov 9, 2026 4:05 PM EST

~ Accepted into the U.S. FDA’s Emerging Technology Program (ETP), enabling early FDA engagement to support development of the RaniPill ® platform technology ~

Read original article